0001209191-17-052585.txt : 20170913
0001209191-17-052585.hdr.sgml : 20170913
20170913160906
ACCESSION NUMBER: 0001209191-17-052585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170911
FILED AS OF DATE: 20170913
DATE AS OF CHANGE: 20170913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FALVEY MICHAEL
CENTRAL INDEX KEY: 0001286197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 171083275
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS INC.
STREET 2: 85 WELLS AVENUE, 2ND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-11
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001286197
FALVEY MICHAEL
C/O KARYOPHARM THERAPEUTICS INC.
NEWTON
MA
02459
0
1
0
0
EVP, CFO & Treasurer
Nonstatutory Stock Option (right to buy)
10.60
2017-09-11
4
A
0
125000
0.00
A
2027-09-10
Common Stock
125000
125000
D
This option was granted on September 11, 2017. The shares underlying this option vest as to 25% of the shares on September 11, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter.
/s/ Christopher B. Primiano, Attorney-in-Fact for Michael Falvey
2017-09-13